IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
Post-transplant Lymphoproliferative Disorder
Jennifer Amengualmonoclonal_antibodyPhase 2Active
BBB
72/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 62/ 100
- Competitive Position
- 89/ 100
Competitive context
17 Active assets in the Post-transplant Lymphoproliferative Disorder cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Cyclophosphamide Washington University School of Medicine | Phase 2 | BBB |
Fludarabine City of Hope Medical Center | Phase 2 | BB |
cc-5013 Northwestern University | Phase 2 | BB |
CYCLOSPORIN A National Cancer Institute (NCI) | Phase 2 | BB |
METHOTREXATE National Cancer Institute (NCI) | Phase 2 | BB |
View all 49 →
Same molecule, other indications
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →